Zobrazeno 1 - 10
of 22
pro vyhledávání: '"N.V. Chmyr"'
The risk of coronary artery disease in patients with type 2 diabetes mellitus and metabolic syndrome
Autor:
N.V. Chmyr, R.Y. Dutka, H.V. Svitlyk, N.M. Hromnatska, I.S. Dronyk, K.J. Abrahamovych, O.Z. Didenko, M.Y. Fedechko, N.V. Drobinska
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 20, Iss 4, Pp 278-285 (2024)
Background. The relevance of this work is due to the growing need for a personalized approach to the management of patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) that arose on the background of metabolic syndrome (MS)
Externí odkaz:
https://doaj.org/article/dcb65cc844604b0a8143fb70ee202c7e
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 19, Iss 3, Pp 200-205 (2023)
Background. Today, there are difficulties with the prevention and diagnosis of early stages of hypertension, especially in active and able-bodied young people. Among the factors that potentiate an increase in blood pressure, one of the components is
Externí odkaz:
https://doaj.org/article/2cab44b08f424bb5be99d0601f980ca8
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 18, Iss 7, Pp 384-389 (2022)
Background. The prevalence of metabolic syndrome (MS), a cluster of risk factors for type 2 diabetes mellitus (DM) and coronary artery disease (CAD), is increasing annually. MS is associated with an almost 2-fold increase in the risk of cardiovascula
Externí odkaz:
https://doaj.org/article/416926440a554549b396e980563bd71f
Autor:
N.V. Chmyr
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 18, Iss 1, Pp 22-35 (2022)
Background. The correlation between renin-angiotensin system and hypothalamic-pituitary system is a pathogenetic link leading to many comorbid diseases, particularly type 2 diabetes mellitus (DM) and coronary artery disease (CAD). Several studies hav
Externí odkaz:
https://doaj.org/article/8f37d1e083844b2189490893710402eb
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 17, Iss 2, Pp 127-135 (2021)
Background. Concomitant diseases due to a combination of metabolic and hormonal changes lead to the development of cardiovascular complications as a direct cause of death and reduced duration or quality of population’s life. The role of hormones in
Externí odkaz:
https://doaj.org/article/51c99fa5eb5b440a951d4d334d200d24
Autor:
N.V. Chmyr
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 14, Iss 8, Pp 740-743 (2018)
Background. Metabolic syndrome (MS) is a topical issue of 21st century, a criterion for type 2 diabetes mellitus (DM) and coronary heart disease (CHD) severity. Violations of lipid, carbohydrate exchange and hormonal state, in particular the function
Externí odkaz:
https://doaj.org/article/356ef6689fd94602bf1ccc95b09b5fe6
Autor:
R.Ya. Dutka, N.V. Chmyr
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 14, Iss 7, Pp 655-660 (2018)
Background. Increase of morbidity of diabetes mellitus (DM) associated with coronary artery disease (CAD) on the background of metabolic syndrome (MS) is worrisome. It is very important to improve the diagnosis of this associated pathology and also t
Externí odkaz:
https://doaj.org/article/dbc4d40b24fb41f0be0003de4ed7c8c8
Autor:
R.Ya. Dutka, N.V. Chmyr
Publikováno v:
Acta Medica Leopoliensia, Vol 23, Iss 3, Pp 10-15 (2017)
Aim. The differences between metabolic syndrome (MS) with obesity with or without comorbid pathology (chronic coronary artery disease i.e. CAD) were explicated in the research. Material and Methods. 126 patients with MS were examined. MS without c
Externí odkaz:
https://doaj.org/article/b2531dbb6b654cf983a2155762d62d8b
Autor:
R.Ya. Dutka, N.V. Chmyr
Publikováno v:
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 14:655-660
Background. Increase of morbidity of diabetes mellitus (DM) associated with coronary artery disease (CAD) on the background of metabolic syndrome (MS) is worrisome. It is very important to improve the diagnosis of this associated pathology and also t
Autor:
N.V. Chmyr
Publikováno v:
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 14:740-743
Актуальність. Метаболічний синдром (МС), в основі якого лежать порушення ліпідного, вуглеводного обміну та гормонального статусу, зокре